# MIDOSTAURIN
> **ANDA215834** · Abbreviated New Drug Application (Generic) · Sponsor: LOTUS PHARM CO LTD · Approved 2022-08-24
## Drug
- **FDA Application Number:** ANDA215834
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MIDOSTAURIN
- **Generic name:** Midostaurin
- **Active ingredients:** MIDOSTAURIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** LOTUS PHARM CO LTD
- **First approval:** 2022-08-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215834)
---
*MORVS · CC0 1.0*